Breaking News
5 hours ago
Vaibhavi M.
Vaxcyte doses first patients in OPUS-3 Phase 3 trial of VAX-31 in previously vaccinated adults.
Vaibhavi M.
Mesoblast shares new data showing early Ryoncil® use improves outcomes and supports a pivotal adult SR-aGvHD trial.
Vaibhavi M.
Biogen names Dr. Maria C. Freire as Board Chair, succeeding Caroline Dorsa after the 2026 Annual Meeting.
Vaibhavi M.
Thermo Fisher and Datavant partner to integrate real-world data with clinical trials using secure, privacy-preserving technology.
Vaibhavi M.